Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125


Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.

Lim ZF, Ma PC.

J Hematol Oncol. 2019 Dec 9;12(1):134. doi: 10.1186/s13045-019-0818-2. Review.


The Journey of an EGFR-Mutant Lung Adenocarcinoma through Erlotinib, Osimertinib and ABCP Immunotherapy Regimens: Sensitivity and Resistance.

Kibirova A, Mattes MD, Smolkin M, Ma PC.

Case Rep Oncol. 2019 Oct 9;12(3):765-776. doi: 10.1159/000503417. eCollection 2019 Sep-Dec.


Primary pleural epithelioid sarcoma of the proximal type: a diagnostic and therapeutic challenge.

Ahmad Z, Stanazai Q, Wright S, Smolkin M, Ma PC.

Transl Lung Cancer Res. 2019 Oct;8(5):700-705. doi: 10.21037/tlcr.2019.09.16.


RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer.

Morgensztern D, Rose M, Waqar SN, Morris J, Ma PC, Reid T, Brzezniak CE, Zeman KG, Padmanabhan A, Hirth J, I Spira A, Trepel JB, Padda SK.

Br J Cancer. 2019 Jul;121(3):211-217. doi: 10.1038/s41416-019-0504-8. Epub 2019 Jun 24.


Phylogeography of Y-chromosome haplogroup Q1a1a-M120, a paternal lineage connecting populations in Siberia and East Asia.

Sun N, Ma PC, Yan S, Wen SQ, Sun C, Du PX, Cheng HZ, Deng XH, Wang CC, Wei LH.

Ann Hum Biol. 2019 Jul 10:1-6. doi: 10.1080/03014460.2019.1632930. [Epub ahead of print]


Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma.

Chen R, Xia W, Wang S, Xu Y, Ma Z, Xu W, Zhang E, Wang J, Fang T, Zhang Q, Dong G, Cho WC, Ma PC, Brandi G, Tavolari S, Ujhazy P, Metro G, Popper HH, Yin R, Qiu M, Xu L.

Mol Ther Nucleic Acids. 2019 Jun 7;16:543-553. doi: 10.1016/j.omtn.2019.04.004. Epub 2019 Apr 13.


Detection of NRG1 Gene Fusions in Solid Tumors.

Jonna S, Feldman RA, Swensen J, Gatalica Z, Korn WM, Borghaei H, Ma PC, Nieva JJ, Spira AI, Vanderwalde AM, Wozniak AJ, Kim ES, Liu SV.

Clin Cancer Res. 2019 Aug 15;25(16):4966-4972. doi: 10.1158/1078-0432.CCR-19-0160. Epub 2019 Apr 15.


(Not Giving Up) The Marathon Race of MET Targeting Therapy: Are We There Yet?

Ma PC.

Clin Cancer Res. 2019 Apr 15;25(8):2375-2378. doi: 10.1158/1078-0432.CCR-18-3739. Epub 2019 Feb 15.


Next-Generation Novel Noninvasive Cancer Molecular Diagnostics Platforms Beyond Tissues.

Wu X, Zhu L, Ma PC.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:964-977. doi: 10.1200/EDBK_199767. Review.


[Accumulation Characteristics and Health Risk Assessment of Heavy Metals in Wild Fish Species from Diaojiang River, Guangxi].

Wang JN, Ma PC, Zhang LJ, Chen MB, Huang CS, Liu XL, Hu GC, Xu ZC.

Huan Jing Ke Xue. 2017 Jun 8;38(6):2600-2606. doi: 10.13227/j.hjkx.201611188. Chinese.


Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM.

N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448.


Durable Near-Complete Response to Anti-PD-1 Checkpoint Immunotherapy in a Refractory Malignant Solitary Fibrous Tumor of the Pleura.

Boothe JT, Budd GT, Smolkin MB, Ma PC.

Case Rep Oncol. 2017 Nov 13;10(3):998-1005. doi: 10.1159/000484041. eCollection 2017 Sep-Dec.


Three-dimensional titanium dioxide/graphene hybrids with improved performance for photocatalysis and energy storage.

Chen L, Yang S, Mu L, Ma PC.

J Colloid Interface Sci. 2018 Feb 15;512:647-656. doi: 10.1016/j.jcis.2017.10.103. Epub 2017 Oct 28.


Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.

Oronsky B, Ma PC, Morgensztern D, Carter CA.

Neoplasia. 2017 Dec;19(12):991-1002. doi: 10.1016/j.neo.2017.09.002. Epub 2017 Nov 5. Review.


Tracking MET de-addiction in lung cancer: A road towards the oncogenic target.

Pilotto S, Carbognin L, Karachaliou N, Ma PC, Rosell R, Tortora G, Bria E.

Cancer Treat Rev. 2017 Nov;60:1-11. doi: 10.1016/j.ctrv.2017.08.002. Epub 2017 Aug 20. Review.


Surface roughness induced superhydrophobicity of graphene foam for oil-water separation.

Yang S, Chen L, Wang C, Rana M, Ma PC.

J Colloid Interface Sci. 2017 Dec 15;508:254-262. doi: 10.1016/j.jcis.2017.08.061. Epub 2017 Aug 18.


YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.

Guo T, Zhao S, Wang P, Xue X, Zhang Y, Yang M, Li N, Li Z, Xu L, Jiang L, Zhao L, Ma PC, Rosell R, Li J, Gu C.

Oncotarget. 2017 Jul 18;8(29):48110-48125. doi: 10.18632/oncotarget.18262.


Widom Lines in Binary Mixtures of Supercritical Fluids.

Raju M, Banuti DT, Ma PC, Ihme M.

Sci Rep. 2017 Jun 8;7(1):3027. doi: 10.1038/s41598-017-03334-3.


AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.

Wu X, Ma W, Zhou Q, Yan H, Lim ZF, Huang M, Deng C, Yu X, Su H, Komo S, Yang H, Zhang X, Wen S, Zhang Z, Ma PC.

J Cancer Res Clin Oncol. 2017 Oct;143(10):1947-1957. doi: 10.1007/s00432-017-2408-4. Epub 2017 May 27.


Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.

Chaib I, Karachaliou N, Pilotto S, Codony Servat J, Cai X, Li X, Drozdowskyj A, Servat CC, Yang J, Hu C, Cardona AF, Vivanco GL, Vergnenegre A, Sanchez JM, Provencio M, de Marinis F, Passaro A, Carcereny E, Reguart N, Campelo CG, Teixido C, Sperduti I, Rodriguez S, Lazzari C, Verlicchi A, de Aguirre I, Queralt C, Wei J, Estrada R, Puig de la Bellacasa R, Ramirez JL, Jacobson K, Ditzel HJ, Santarpia M, Viteri S, Molina MA, Zhou C, Cao P, Ma PC, Bivona TG, Rosell R.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx014.


Special issue: "MET as actionable target in cancer therapy".

Ma PC.

Ann Transl Med. 2017 Jan;5(1):1. doi: 10.21037/atm.2017.01.10. No abstract available.


Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming.

Thiagarajan PS, Wu X, Zhang W, Shi I, Bagai R, Leahy P, Feng Y, Veigl M, Lindner D, Danielpour D, Yin L, Rosell R, Bivona TG, Zhang Z, Ma PC.

Oncotarget. 2016 Dec 13;7(50):82013-82027. doi: 10.18632/oncotarget.13307.


Inhibition of YAP/TAZ Activity in Spinal Cord Suppresses Neuropathic Pain.

Xu N, Wu MZ, Deng XT, Ma PC, Li ZH, Liang L, Xia MF, Cui D, He DD, Zong Y, Xie Z, Song XJ.

J Neurosci. 2016 Sep 28;36(39):10128-40. doi: 10.1523/JNEUROSCI.0800-16.2016. Epub 2016 Sep 28.


Activation of ephrinB-EphB receptor signalling in rat spinal cord contributes to maintenance of diabetic neuropathic pain.

Deng XT, Wu MZ, Xu N, Ma PC, Song XJ.

Eur J Pain. 2017 Feb;21(2):278-288. doi: 10.1002/ejp.922. Epub 2016 Jul 27.


Simultaneous quantification of chlorogenic acid and taurocholic acid in human plasma by LC-MS/MS and its application to a pharmacokinetic study after oral administration of Shuanghua Baihe tablets.

Gu P, Liu RJ, Cheng ML, Wu Y, Zheng L, Liu YJ, Ma PC, Ding L.

Chin J Nat Med. 2016 Apr;14(4):313-320. doi: 10.1016/S1875-5364(16)30034-6.


Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib.

Hembrough T, Liao WL, Hartley CP, Ma PC, Velcheti V, Lanigan C, Thyparambil S, An E, Monga M, Krizman D, Burrows J, Tafe LJ.

Clin Chem. 2016 Jan;62(1):252-61. doi: 10.1373/clinchem.2015.245860. Epub 2015 Nov 19.


Wnt/Ryk signaling contributes to neuropathic pain by regulating sensory neuron excitability and spinal synaptic plasticity in rats.

Liu S, Liu YP, Huang ZJ, Zhang YK, Song AA, Ma PC, Song XJ.

Pain. 2015 Dec;156(12):2572-84. doi: 10.1097/j.pain.0000000000000366.


MET receptor juxtamembrane exon 14 alternative spliced variant: novel cancer genomic predictive biomarker.

Ma PC.

Cancer Discov. 2015 Aug;5(8):802-5. doi: 10.1158/2159-8290.CD-15-0769.


RET-rearranged lung adenocarcinomas with lymphangitic spread, psammoma bodies, and clinical responses to cabozantinib.

Mukhopadhyay S, Pennell NA, Ali SM, Ross JS, Ma PC, Velcheti V.

J Thorac Oncol. 2014 Nov;9(11):1714-9. doi: 10.1097/JTO.0000000000000323.


Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib.

Agwa ES, Ma PC.

Cancer Manag Res. 2014 Oct 4;6:397-404. doi: 10.2147/CMAR.S37345. eCollection 2014. Review.


EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).

Reynolds JP, Tubbs RR, Minca EC, MacNamara S, Almeida FA, Ma PC, Pennell NA, Cicenia JC.

Lung Cancer. 2014 Nov;86(2):158-63. doi: 10.1016/j.lungcan.2014.09.003. Epub 2014 Sep 22.


Acquired trichomegaly: trichomegaly secondary to erlotinib.

Medina Mendez CA, Ma PC, Singh AD.

JAMA Ophthalmol. 2014 Sep;132(9):1051. doi: 10.1001/jamaophthalmol.2014.545. No abstract available.


Controlled synthesis of hierarchical TiO2 nanoparticles on glass fibres and their photocatalytic performance.

Chen L, Yang S, Mäder E, Ma PC.

Dalton Trans. 2014 Sep 7;43(33):12743-53. doi: 10.1039/c4dt00977k.


Magnetic graphene foam for efficient adsorption of oil and organic solvents.

Yang S, Chen L, Mu L, Ma PC.

J Colloid Interface Sci. 2014 Sep 15;430:337-44. doi: 10.1016/j.jcis.2014.05.062. Epub 2014 Jun 9.


ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material.

Minca EC, Lanigan CP, Reynolds JP, Wang Z, Ma PC, Cicenia J, Almeida FA, Pennell NA, Tubbs RR.

J Thorac Oncol. 2014 Apr;9(4):464-8. doi: 10.1097/JTO.0000000000000104.


High MET receptor expression but not gene amplification in ALK 2p23 rearrangement positive non-small-cell lung cancer.

Feng Y, Minca EC, Lanigan C, Liu A, Zhang W, Yin L, Pennell NA, Farver C, Tubbs R, Ma PC.

J Thorac Oncol. 2014 May;9(5):646-53. doi: 10.1097/JTO.0000000000000145.


Microwave field controlled slow and fast light with a coupled system consisting of a nanomechanical resonator and a Cooper-pair box.

Ma PC, Xiao Y, Yu YF, Zhang ZM.

Opt Express. 2014 Feb 10;22(3):3621-8. doi: 10.1364/OE.22.003621.


All-trans retinoic acid induces cell-cycle arrest in human cutaneous squamous carcinoma cells by inhibiting the mitogen-activated protein kinase-activated protein 1 pathway.

Zhang ML, Tao Y, Zhou WQ, Ma PC, Cao YP, He CD, Wei J, Li LJ.

Clin Exp Dermatol. 2014 Apr;39(3):354-60. doi: 10.1111/ced.12227.


Choroidal metastases responsive to crizotinib therapy in a lung adenocarcinoma patient with ALK 2p23 fusion identified by ALK immunohistochemistry.

Feng Y, Singh AD, Lanigan C, Tubbs RR, Ma PC.

J Thorac Oncol. 2013 Dec;8(12):e109-11. doi: 10.1097/01.JTO.0000437502.82078.9b. No abstract available.


Development of carbon nanotubes/CoFe2O4 magnetic hybrid material for removal of tetrabromobisphenol A and Pb(II).

Zhou L, Ji L, Ma PC, Shao Y, Zhang H, Gao W, Li Y.

J Hazard Mater. 2014 Jan 30;265:104-14. doi: 10.1016/j.jhazmat.2013.11.058. Epub 2013 Dec 4.


Overview of various techniques/platforms with critical evaluation of each.

Agwa E, Ma PC.

Curr Treat Options Oncol. 2013 Dec;14(4):623-33. doi: 10.1007/s11864-013-0259-z. Review.


ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.

Minca EC, Portier BP, Wang Z, Lanigan C, Farver CF, Feng Y, Ma PC, Arrossi VA, Pennell NA, Tubbs RR.

J Mol Diagn. 2013 May;15(3):341-6. doi: 10.1016/j.jmoldx.2013.01.004. Epub 2013 Mar 13.


Cancer genes in lung cancer: racial disparities: are there any?

El-Telbany A, Ma PC.

Genes Cancer. 2012 Jul;3(7-8):467-80. doi: 10.1177/1947601912465177.


Combined treatment with MET inhibitors and other therapies in lung cancer.

Bagai R, Ma PC.

Transl Lung Cancer Res. 2012 Sep;1(3):214-8. doi: 10.3978/j.issn.2218-6751.2012.09.07. No abstract available.


MET targeted therapy for lung cancer: clinical development and future directions.

Feng Y, Ma PC.

Lung Cancer (Auckl). 2012 Aug 9;3:53-67. doi: 10.2147/LCTT.S23423. eCollection 2012. Review.


Triptolide inhibits proliferation and induces apoptosis of human melanoma A375 cells.

Tao Y, Zhang ML, Ma PC, Sun JF, Zhou WQ, Cao YP, Li LJ.

Asian Pac J Cancer Prev. 2012;13(4):1611-5.


Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.

Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG.

Nat Genet. 2012 Jul 1;44(8):852-60. doi: 10.1038/ng.2330.


Two generations of light/never-smokers with advanced adenocarcinoma of the lung with durable responses to erlotinib.

Pennell NA, Yin L, Keshtgarpour M, Ma PC.

J Thorac Oncol. 2012 Jul;7(7):1200-1. doi: 10.1097/JTO.0b013e318250ed89. No abstract available.


Personalized targeted therapy in advanced non-small cell lung cancer.

Ma PC.

Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS56-60. doi: 10.3949/ccjm.79.s2.12. Review.


Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer.

Feng Y, Ma PC.

Cancer Discov. 2011 Dec;1(7):550-4. doi: 10.1158/2159-8290.CD-11-0289.

Supplemental Content

Support Center